IBRN Holdings
79 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | BIOGEN | 4.87% | 1,396 | $310.1K |
| 2 | NEUROCRINE BIOSCIENCES | 4.46% | 1,981 | $284.2K |
| 3 | EDGEWISE THERAPEUTICS | 4.44% | 7,148 | $282.8K |
| 4 | PTC THERAPEUTICS | 4.41% | 4,446 | $281.1K |
| 5 | ARGENX SE ADR | 4.36% | 299 | $277.6K |
| 6 | ALKERMES | 4.35% | 6,686 | $277.1K |
| 7 | PRAXIS PRECISION MEDICINES | 3.82% | 875 | $243.3K |
| 8 | DIANTHUS THERAPEUTICS INC | 3.79% | 2,848 | $241.7K |
| 9 | SCHOLAR ROCK HOLDING | 3.68% | 5,565 | $234.8K |
| 10 | SUPERNUS PHARMACEUTICALS | 3.58% | 5,299 | $228.1K |
| 11 | ACADIA PHARMACEUTICALS | 3.39% | 10,995 | $216.1K |
| 12 | SK BIOPHARMACEUTICALS LTD (326030.KS) | 3.39% | 3,810 | $216.0K |
| 13 | DYNE THERAPEUTICS | 3.18% | 12,682 | $202.5K |
| 14 | XENON PHARMACEUTICALS | 2.95% | 5,158 | $187.8K |
| 15 | AXOGEN | 2.88% | 5,092 | $183.5K |
| 16 | H. LUNDBECK CLASS B (HLUN-B.CO) | 2.76% | 26,061 | $175.9K |
| 17 | SAREPTA THERAPEUTICS | 2.70% | 9,823 | $171.9K |
| 18 | NEUREN PHARMACEUTICALS (NEU.AX) | 2.35% | 10,697 | $149.9K |
| 19 | BIOHAVEN | 2.33% | 12,496 | $148.5K |
| 20 | BIOARCTIC CLASS B (BIOA-B.ST) | 1.92% | 4,158 | $122.6K |
| 21 | TAYSHA GENE THERAPIES | 1.79% | 25,694 | $113.8K |
| 22 | ONCOLYS BIOPHARMA INC (4588.T) | 1.58% | 2,500 | $100.4K |
| 23 | IDORSIA N LTD (IDIA.SW) | 1.49% | 18,238 | $95.0K |
| 24 | LB PHARMACEUTICALS INC | 1.38% | 2,568 | $87.7K |
| 25 | RAPPORT THERAPEUTICS | 1.35% | 2,790 | $86.1K |
Sector Weights
- Healthcare: 100.00%
Country Weights
- United States: 66.62%
- Ireland: 4.89%
- Netherlands: 4.34%
- South Korea: 3.39%
- Canada: 3.17%
- Sweden: 3.09%
- Denmark: 2.74%
- Australia: 2.35%
- Japan: 2.26%
- Switzerland: 1.88%
- China: 1.43%
- India: 1.30%
- France: 1.08%
- Israel: 0.66%
- Other: 0.57%
- Italy: 0.25%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.